University of Saskatchewan’s Dr. Diego Moya named 2024 Metacam® Bovine Welfare Award winner

September 12, 2024 – Dr. Diego Moya of the University of Saskatchewan has been named the recipient of the 2024 Metacam^® Bovine Welfare Award for his outstanding contributions to research, education, and public service, significantly advancing the scientific understanding of bovine welfare and implementing improvements within this field.

The Metacam^® Bovine Welfare Award is presented annually by the Canadian Association of Bovine Veterinarians (CABV) / Association Canadienne des Vétérinaires Bovins (ACVB) in partnership with Boehringer Ingelheim Animal Health Canada Inc. Dr. Moya was announced as the award winner at the Annual General Meeting of the CABV/ACVB in Columbus, Ohio on Sept. 12, 2024. 

"The CABV/ACVB extends its congratulations to Dr. Diego Moya,” said Dr. Jodi Wallace, President of the CABV/ACVB. “Dr. Moya’s passion for animal welfare, that is so well reflected in his research and in all of his professional activities, has been a great benefit to cattle and to those who work with cattle."

Dr. Moya is an Assistant Professor in the Department of Large Animal Clinical Sciences at the University of Saskatchewan. His research focuses on how nutritional management can enhance animal welfare, how to mitigate pain associated with castration in beef cattle and investigating the connections between animal welfare, behaviour, and disease. 

In addition to his research, Dr. Moya is a strong advocate for animal welfare in modern agriculture, serving on animal welfare committees, including the Saskatchewan Veterinary Medical Association Animal Welfare Committee and the University of Saskatchewan Scientific Merit Review Committee for Animal-Based Research.

“I am deeply honoured to receive the 2024 Metacam Bovine Welfare Award,” Dr. Moya said. “I am grateful for this award and the opportunity to join the ranks of esteemed past recipients who have all made substantial contributions to improving bovine welfare. This recognition also reflects the unwavering support I have received from my colleagues and mentors.”

In his support for the award nomination, Dr. Christopher Luby, Associate Professor and Head Department of Large Animal Clinical Science, said Dr. Moya is a recognized leader in bovine welfare.

“Dr. Moya has significantly advanced our scientific understanding of bovine welfare and implemented improvements in this field,” said Dr. Luby. “He has shown exceptional leadership in imparting the science, ethics and culture of animal welfare to the next generation of veterinarians and animal scientists.”

Derek Groff, Business Unit Director (Livestock) with Boehringer Ingelheim Animal Health Canada, explained the Metacam^® Bovine Welfare Award recognizes and encourages those who research and work to advance animal welfare and well-being.

“Dr. Moya’s dedication and passion is recognized through his invaluable research and leadership in animal welfare, significantly benefiting the cattle industry,” Groff said. “We congratulate Dr. Moya for his profound impact and contributions to the advancement of bovine welfare in Canada.” 

Groff thanked the CABV/ACVB for its work to seek nominations and select the recipient of the award.

About CABV/ACVB

The Canadian Association of Bovine Veterinarians (CABV) / Association Canadienne des Vétérinaires Bovins (ACVB) represents approximately 800 veterinarians from across Canada who have a specific interest in bovine health and production medicine. The Board is composed of twelve members who are also representatives on the Boards of Canada’s four regional bovine associations: Atlantic Bovine Practitioners Association (ABPA), l'Association des Médecins Vétérinaires Praticiens du Québec (AMVPQ), Ontario Association of Bovine Practitioners (OABP) and the Western Canadian Association of Bovine Practitioners (WCABP).

Boehringer Ingelheim (Canada) Ltd. 

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow. The Canadian headquarters of Boehringer Ingelheim was established in 1972 in Montreal, Quebec and is now located in Burlington, Ontario. Boehringer Ingelheim employs approximately 500 people across Canada. Learn more at www.boehringer-ingelheim.com/ca

About Boehringer Ingelheim Animal Health

Boehringer Ingelheim provides innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to make a difference for people, animals, and society. Learn more at www.boehringer-ingelheim.com/ca/animal-health 

About the Metacam^® Bovine Welfare Award

The Metacam^® Bovine Welfare Award is given annually to a DVM or animal scientist working in Canada, a faculty member or a graduate student of a Canadian university to recognize his/her achievements in advancing the welfare of animals via leadership, public service, education, research/product development, and/or advocacy. By doing so, the CABV/ACVB hopes to raise public awareness of the important role veterinarians and animal scientists play in:

• Improving bovine welfare in cattle production and research systems
• Improving scientific methods of measuring bovine welfare

*Registered trade names: Metacam^® 20 mg/mL Solution for Injection and Metacam^® 40 mg/mL Solution for Injection

Metacam^® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license.